Minerva Neurosciences Inc — Cash Flow (NASDAQ:NERV) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 33.8 M24.6 M24.6 M14.8 M19.6 M 42.98 M Cash from investing activities 24.53 M24.53 M-16.33 K-16.33 K0 0 Cash from financing activities 13.24 M60 M-519.6 M19.6 M — Free cash flow 33.8 M24.6 M24.58 M14.8 M19.6 M 42.98 M

新闻

Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript

明瑞神经科学公司任命精神分裂症专家加入董事会

Minerva Neurosciences appoints schizophrenia expert to board of directors

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.47%

美国股市涨跌不一；截至收盘道琼斯工业平均指数上涨0.47%

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial - Minerva Neurosciences (NASDAQ:NERV)

Minerva Neurosciences股价飙升，获得2亿美元融资

Minerva Neurosciences stock soars after securing $200 million financing

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - American Rebel Holdings (NASDAQ:AREB), Beyond Meat (NASDAQ:BYND)